Dave Johnson
8Patents
3h-index
14Co-inventors
54Inventor score
Filing activity: Nov 13, 1998 → Aug 16, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10272083B2 | Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor | Chemistry; Metallurgy | 8 | Active |
| US11771696B2 | Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor | Chemistry; Metallurgy | 3 | Active |
| US9949971B2 | Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor and/or a JAK-2 inhibitor | Chemistry; Metallurgy | 3 | Active |
| US10328080B2 | Therapeutic combination of PI3K inhibitor and a BTK inhibitor | Human Necessities | 2 | Active |
| US11090302B2 | Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor | Chemistry; Metallurgy | 2 | Active |
| US6211202A | 2-methoxyimino-2-(pyridinyloxymethyl) phenyl acetamides with substituted ketal derivatives on the pyridine ring | Human Necessities | 1 | Expired |
| US11166951B2 | Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JAK-2 inhibitor, and/or a BCL-2 inhibitor | Human Necessities | 1 | Active |
| US12263164B2 | Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.